Clinically relevant animal model of human breast cancer and VEGF involvement in desmoplastic response,tamoxifen resistance and metastasis

Details for Australian Patent Application No. 2004214892 (hide)

Owner Southern Research Institute

Inventors Qu, Zhican; Kern, Frances

Agent EF WELLINGTON & CO

Pub. Number AU-B-2004214892

PCT Pub. Number WO2004/076648

Priority 60/449,980 26.02.03 US

Filing date 26 February 2004

Wipo publication date 10 September 2004

Acceptance publication date 22 January 2009

International Classifications

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A01K 67/00 (2006.01) Rearing or breeding animals, not otherwise provided for

A01K 67/033 (2006.01) Rearing or breeding animals, not otherwise provided for

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 1/00 (2006.01) Micro-organisms, e.g. protozoa

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

22 September 2005 PCT application entered the National Phase

  PCT publication WO2004/076648 Priority application(s): WO2004/076648

24 May 2007 Assignment before Grant

  The UAB Research Foundation The application has been assigned to Southern Research Institute

22 January 2009 Application Accepted

  Published as AU-B-2004214892

28 May 2009 Corrigenda

  Applications Accepted - Name Index Under the name Southern Research Institute, Application No. 2004214892, under INID(54) correct the title to read Clinically relevant animal model of human breast cancer and VEGF involement in desmoplastic response Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journal date. 2002316135 Sirna Therapeutics, Inc. 2004214795 Panasonic Corporation 2005

4 June 2009 Application for Amendment

  The nature of the amendment is: Amend the invention title to read Clinically relevant animal model of human breast cancer and VEGF involvement in desmoplastic response, tamoxifen resistance and metastasis. Address for service in Australia - EF WELLINGTON & CO 312 St Kilda Road Southbank MELBOURNE VIC 3006

24 September 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Clinically relevant animal model of human breast cancer and VEGF involvement in desmoplastic response, tamoxifen resistance and metastasis

1 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004214896-Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines

2004214891-Random array DNA analysis by hybridization